Literature DB >> 33772457

Advancement of echocardiography for surveillance of iron overload cardiomyopathy: comparison to cardiac magnetic resonance imaging.

M Jason Zimmerman1, Douglas R Rosing2, Yukitaka Shizukuda2,3,4.   

Abstract

The prevalence of iron overload cardiomyopathy (IOC) is increasing. Patients with transfusion-dependent anemias or conditions associated with increased iron absorption over time are at a significant risk for the development of iron-overloaded states such as IOC. Current guidelines regarding the diagnostic evaluation and follow-up of patients at risk for IOC exist, and are composed of multiple components, including such as echocardiography, genetic testing, magnetic resonance imaging of liver, and cardiac magnetic resonance imaging (CMR). While these are considered reliable for the evaluation of patients at risk for an iron-overloaded state, there is an access challenge associated with initial and serial CMR scanning in this patient population. Furthermore, there are other limiting factors, such as patient characteristics that may preclude the use of CMR as a viable diagnostic imaging modality for these patients. On the other hand, recent evidence in the literature suggests that transthoracic echocardiography, which has had significant technological advances, can equal or even outperform CMR to identify cardiac functional abnormalities such as subclinical left ventricular strain and left atrial functional abnormalities in iron overload conditions. Therefore, there is a potential role of more frequent use of echocardiography for surveillance of the development of IOC. Our purpose with this narrative review is to describe recent advances in echocardiography and propose a potential increased use of echocardiography in the surveillance of the development of IOC.
© 2021. Japanese Society of Echocardiography.

Entities:  

Keywords:  Cardiac magnetic resonance imaging; Cardiomyopathy; Echocardiography; Iron overload; Surveillance

Year:  2021        PMID: 33772457     DOI: 10.1007/s12574-021-00524-x

Source DB:  PubMed          Journal:  J Echocardiogr        ISSN: 1349-0222


  57 in total

Review 1.  Iron overload cardiomyopathy in clinical practice.

Authors:  Dimitrios T Kremastinos; Dimitrios Farmakis
Journal:  Circulation       Date:  2011-11-15       Impact factor: 29.690

Review 2.  Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives.

Authors:  Dimitrios T Kremastinos; Dimitrios Farmakis; Athanasios Aessopos; George Hahalis; Eftychia Hamodraka; Dimitrios Tsiapras; Andre Keren
Journal:  Circ Heart Fail       Date:  2010-05       Impact factor: 8.790

Review 3.  Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment.

Authors:  Colm J Murphy; Gavin Y Oudit
Journal:  J Card Fail       Date:  2010-07-03       Impact factor: 5.712

Review 4.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

Review 5.  Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.

Authors:  G D McLaren; W A Muir; R W Kellermeyer
Journal:  Crit Rev Clin Lab Sci       Date:  1983       Impact factor: 6.250

6.  L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy.

Authors:  Gavin Y Oudit; Hui Sun; Maria G Trivieri; Sheryl E Koch; Fayez Dawood; Cameron Ackerley; Mehrdad Yazdanpanah; Greg J Wilson; Arnold Schwartz; Peter P Liu; Peter H Backx
Journal:  Nat Med       Date:  2003-08-24       Impact factor: 53.440

Review 7.  Cardiac iron across different transfusion-dependent diseases.

Authors:  John C Wood
Journal:  Blood Rev       Date:  2008-12       Impact factor: 8.250

Review 8.  Iron overload cardiomyopathies: new insights into an old disease.

Authors:  P Liu; N Olivieri
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

Review 9.  Concepts and goals in the management of transfusional iron overload.

Authors:  John B Porter
Journal:  Am J Hematol       Date:  2007-12       Impact factor: 10.047

10.  Longitudinal analysis of heart and liver iron in thalassemia major.

Authors:  Leila J Noetzli; Susan M Carson; Anne S Nord; Thomas D Coates; John C Wood
Journal:  Blood       Date:  2008-07-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.